FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Track all the latest updates and news of Mankind Pharma IPO.
November 22, 2024 9:23:00 AM
The round was led by Motilal Oswal Private Wealth and also saw participation from investors, including Raamdeo Agarwal, the Taparia Family Office, Mankind Pharma Family Office, RP Sanjiv Goenka Group, ...
Published by : Entrepreneur on MSNNovember 23, 2024 6:52:31 AM
This fundraise also saw participation from family offices and investors such as Motilal Oswal AMC and Raamdeo Agarwal, the Taparia Family Office, Mankind Pharma Family Office, RP Sanjiv Goenka Group, ...
Published by : The New Indian Express on MSNNovember 19, 2024 11:22:00 PM
Onyx Biotec’s IPO allotment will be finalised on November 20. The IPO, valued at ?29.34 crore, opened on November 13 and closed on November 18, garnering strong demand from investors. The listing on ...
Published by : MintNovember 22, 2024 5:00:00 AM
Quick commerce major Zepto on Friday announced that it has raised a massive $350 million in its latest round at a flat valuation of $5 billion, led by Motilal Oswal’s Private Wealth division. The move ...
Published by : Business StandardNovember 22, 2024 10:21:00 AM
IPO-bound quick commerce firm Zepto has raised another $350 million in its third funding round this year, led by Motilal Oswal’s private wealth division, per an announcement. The round saw ...
Published by : dealstreetasiaOctober 24, 2024 9:35:00 PM
Mankind Pharma Limited on Wednesday announced that it has completed the transaction to acquire 100% stake in Bharat Serums and Vaccines Limited (BSV), for a purchase consideration of Rs.
Published by : The Financial ExpressNovember 22, 2024 9:31:00 AM
The latest capital infusion will add to Zepto’s war chest, enabling it to compete with its larger rival Zomato-owned Blinkit and other players in the 10-minute goods delivery model in the e-commerce ...
Published by : The Financial ExpressNovember 22, 2024 4:00:00 AM
Zepto’s valuation remains steady at $5 billion. The funding adds to Zepto’s impressive 2024 trajectory, which has seen the company raise over $1 billion.
Published by : cnbctv18November 22, 2024 10:58:00 PM
The company's shares opened at Rs 54.05, reflecting an 11.39 percent discount from its initial public offering (IPO) price of Rs 61 per share. The Pharmaceutical company has earmarked Rs 6.08 crore ...
Published by : Mena FNThe IPO Shares of Mankind Pharma Limited IPO are proposed to list on Tuesday, May 9, 2023 at BSE, NSE. The public issue of Mankind Pharma IPO was opened on Apr 25, 2023 and closed for subscription on Apr 27, 2023. Mankind Pharma IPO Listing Date and Information:
Listing Date | Tuesday, May 9, 2023 |
BSE Script Code | 543904 |
NSE Symbol | MANKIND |
Listing In | B Group of Securities |
ISIN | INE634S01028 |
Issue Price | [.] |
Face Value | ₹1 Per Equity Share |
The allotment status of Mankind Pharma Limited IPO is now available online. The public issue of Mankind Pharma IPO was open on Apr 25, 2023 and closed for subscription on Apr 27, 2023. The equity shares of the company to be list at BSE, NSE
.
Mankind Pharma Limited is entering in the capital market with an IPO of 40,058,844 Equity Shares of Rs 1 aggregating up to Rs 4,326.36 Crore. The price for the issue has been set at Rs 1026 - Rs 1080 Per Equity Share.
Incorporated in 1991, Mankind Pharma Limited develops, manufactures, and markets pharmaceutical formulations across various acute and chronic therapeutic areas and several consumer healthcare products.
The issue opens on Apr 25, 2023 and closes for subscription on Apr 27, 2023. The equity shares of the company to be list at BSE, NSE.
The issue of Mankind Pharma Limited opens on Apr 25, 2023 and closes for subscription on Apr 27, 2023. The equity shares of the company to be list at BSE, NSE. The price for the issue has been set at Rs 1026 - Rs 1080 Per Equity Share.
The Mankind Pharma IPO is proposed to open on April 25, 2023. The IPO application ends on April 27, 2023.
Retail investors can apply in the retail or non-institutional investor category from April 25, 2023 to April 27, 2023. The Mankind Pharma IPO can be applied online through Net Bank (ASBA method) or the stock broker (UPI method).
The Mankind Pharma IPO will open for subscription on April 25, 2023. The public issue will close on April 27, 2023.
Useful Articles
Rs 0 Account Opening Fee
Free Eq Delivery & MF
Flat ₹20 Per Trade in F&O
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|